Advanced search
Publication Cover
Acta Odontologica Scandinavica Volume 59, 2001 - Issue 5
Journal homepage
139
Views
30
CrossRef citations to date
0
Altmetric
Research Article

A revisit of mucosal IgA immunity and oral tolerance

Kohtaro Fujihashi The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Hirotomo Kato The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Frederik W. Van Ginkel The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Toshiya Koga The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Prosper N. Boyaka The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Raymond J. Jackson The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Rie Kato The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Yukari Hagiwara The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Yuri Etani The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Iwao Goma The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Keiko Fujihashi The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
,
Hiroshi Kiyono The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
&
Jerry R. McGhee The Departments of Oral Biology and Microbiology, The Immunobiology Vaccine Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA
 show all
Pages 301-308 | Published online: 02 Jul 2009

  • McGhee JR, Kiyono H. Mucosal immunology. In: Paul WE, editor. Fundamental immunology. 4th ed. San Diego (CA): Academic Press;1999. p. 909-45.
  • McGhee JR, Lamm ME, Strober W. Mucosal immune responses: an overview. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal immunology. 2nd ed. San Diego (CA) Academic Press;1999. p. 485-506.
  • Kato T, Owen RL. Structure and function of intestinal mucosal epithelium. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal immunology. 2nd ed. San Diego (CA): Academic Press;1999. p. 115-32.
  • Tomasi TB. Oral tolerance. Transplantation 1980,29:353-6.
  • Mowat AM. The regulation of immune responses to dietary protein antigens. Immunol Today 1987;8:93-8.
  • Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, et al. Oral tolerance: immunologie mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-37.
  • Challacombe SJ, Tomasi TB. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 1980;152:145972.
  • Mowat AM, Weiner HL. Oral tolerance: physiological basis and clinical applications. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal immunology. 2nd ed. San Diego (CA) Academic Press;1998. p. 587-618.
  • Mayer L. Oral tolerance: new approaches, new problems. Clin Immunol 2000,94:1-8.
  • Wardrop RM, Whitacre CC. Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm Res 1999;48:10619.
  • MacDonald, TT. T cell immunity to oral allergens. Curr Opin Immunol 1998;10:620-7.
  • Holt PG. Mucosal immunity in relation to the development of oral tolerance/sensitization. Allergy 1998;53:16-9.
  • Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998;19:173-81.
  • Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998;18: l-30.
  • Fujihashi, K, McGhee JR, Yamamoto M, Hiroi T, Kiyono H. Role of cells in the regulation of mucosal IgA response and oral tolerance. Ann NY Acad Sci 1996;778:55-63.
  • Thomas HC, Parrott MV. The induction of tolerance to a soluble protein antigen by oral administration. Immunology 1974;27:631-9.
  • Kagnoif MF. Effects of antigen-feeding on intestinal and systemic immune responses. IV. Similarity between the suppressor factor in mice after erythrocyte-lysate injection and erythrocyte feeding. Gastroenterology 1980;79:4-61.
  • Kiyono H, Babb JL, Michalek SM, McGhee JR. Cellular basis for elevated IgA responses in C3H/HeJ mice. J Immunol 1980;125:732-7.
  • Kiyono H, McGhee JR, Wannemuehler MJ, Michalek SM. Lack of oral tolerance in CSH/HeJ mice. J Exp Med 1982;155:60510.
  • Mattingly JA, Waksman BH. Immunologie suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration. J Immunol 1978;121:1878-83.
  • Mowat AM, Lamont AG, Parrott DM. Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin. Immunology 1988;64:141-5.
  • Richman LK, Graeff AS, Yarchoan R, Strober W. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in Ae murine Peyer's patch after protein feeding. J Immunol 1981;126:2079-83.
  • Ngan J, Kind LS. Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol 1978;120:861-5.
  • Elson CO, Balding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984;132:2736-41.
  • Xu-Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, et al. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993;178:1309-20.
  • Clements JD, Hartzog NM, Lyon FL. Adjuvant activity of Escherictua coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988;6:269-77.
  • Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 1995;155:4621-9.
  • Takahashi I, Kiyono H, Marinaro M, Jackson RJ, Nakagawa I, Fujihashi K, et al. Mechanisms for mucosal immunogenicity and adjuvanticity of Escherichia coli labile enterotoxin. J Infect Dis 1996;173:627-35.
  • Tsuji T, Inoue T, Miyama A, Okamoto K, Honda T, Miwatani T. A single amino acid substitution in the A subunit of EscheriMa coK enterotoxin results in a loss of its toxic activity. J Biol Chem 1990;265:22520-5.
  • Sixma TK, Pronk SE, KaIk KH, van Zanten BA, Berghuis AM, Hol WG. Lactose binding to heat labile enterotoxin revealed by X-ray crystallography. Nature 1992;355:561 -4.
  • Lycke N, Tsuji T, Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 1992;22:2277-81.
  • Komase K, Tamura S-I, Matsuo K, Watanabe K, Hattori N, Odaka A, et al. Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1998;16:24854.
  • Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Nad Acad Sci USA 1995;92:1644-8.
  • Dickinson BL, Clements JD. Dissociation of Escherichia coli heatlabile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 1995;63:1617-23.
  • Pizza M, Domenighini M, Hol W, Giannelli V, Fontana MR, Giuliani MM, et al. Probing the structure-activity relationship of EschaicMa colt LT-A by site-directed mutagenesis. MoI Microbiol 1994;14:51-60.
  • Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, et al. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant Infect Immun 1996;64:9749.
  • Yamamoto S, Takeda Y, Yamamoto M, Kurazono H, Imaoka K, Yamamoto M, et al. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrhoeagenicity but retain adjuvanticity. J Exp Med 1997;185:1203-10.
  • Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Yamamoto M, Fujihashi K, et al. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997;94:5267-72.
  • Lencer WI, Hirst TR, Holmes RK. Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1999;1450:177-90.
  • Bourguignon P, Bisteau M, Abarca J, Veenstra S, Hermand P, Henderickx V, et al. Reactogeniaty in the nose and the brain of enterotoxins administered intranasally to mice. In: Proceedings of the Cold Spring Harbor Conference on Molecular Approaches to Vaccine Design;1999 Dec 2-5. p. 23.
  • van Ginkel FW, Jackson, RJ, Yuki Y, McGhee JR. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 2000;165:4778-82.
  • Koga T, McGhee JR, Kato H, Kato R, Kiyono H, Fujihashi K. Evidence for early aging in the mucosal immune system. J Immunol 2000;165:5352-9.
  • Czerkinsky C, Anjuere F, McGhee JR, George-Chandy A, Holmgren J, Kieny MP, et al. Mucosal immunity and tolerance: relevance to vaccine development Immunol Rev 1999;170:197222.
  • Elson CO, Balding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol 1984;133:2892-7.
  • Kato H, Fujihashi K, Kato R, McGhee JR. Prior oral tolerization abrogates cholera toxin-induced IgA responses in gastrointestinal tract. J Immunol 2001;166:3114-21.
  • De Togni P, Goellner J, Ruddle NH, Streeter PR, Pick A, Mariathasan S, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-7.
  • Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, et al. Lymphotoxin-a-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995;155:1685-93.
  • Alimzhanov MB, Kuprash DV, Kosco VM, Luz A, Turetskaya RL, Tarakhovsky A, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin ß-deficient mice. Proc Natl Acad Sci USA 1997;94:9302-7.
  • Koni PA, Sacca R, Lawton P, BrowningJL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins a and ß revealed in lymphotoxin ß-deficient mice. Immunity 1997;6:491-500.
  • Koni PA, Flavell RA. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin ß. J Exp Med 1998;187:1977-83.
  • Futterer A, Mink K, Luz A, Kosco VM, Pfeffer K. The lymphotoxin ß receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998;9:5970.
  • Rennert PD, BrowningJL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin a/ß complex is required for the development of peripheral lymphoid organs. J Exp Med 1996;184:19992006.
  • Rennert PD, James D, Mackay F, BrowningJL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin ß receptor. Immunity 1998;9:71-9.
  • Rennert PD, Browning JL, Hochman PS. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Intern Immunol 1997;9:1627-39.
  • Fujihashi K, Dohi T, Rennert PD, Koga T, Kiyono H, McGhee JR. Peyer's patches are required for oral tolerance to proteins. Proc Nad Acad Sci USA 2001;98:3310-5.
  • Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut Infect Immun 1995;63 3904-13.
  • Wannemuehler MJ, Kiyono H, BabbJL, Michalek SM, McGhee JR. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J Immunol 1982;129:959-65.
  • Kramer DR, Cebra JJ. Early appearance of "natural" mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies. J Immunol 1995;154:2051-62.
  • Coffman RL, Lebman DA, Shrader B. Transforming growth factor specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:1039-44.
  • Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, et al. Transforming growth factor ß induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 1989;170:1415-20.
  • Mowat AM, Steel M, Leishman AJ, Garside P. Normal induction of oral tolerance in the absence of a functional IL-12-dependent IFN-y signaling pathway. J Immunol 1999;163:4728-36.
  • Gomella PA, Chen Y, Inobe J, Komagata Y, Quartulli M, Weiner HL. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J Immunol 1998;160:4708 -18.
  • Yamamoto M, Rennert PD, McGhee JR, Kweon M-N, Yamamoto S, Dohi T, et al. An alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the GI tract J Immunol 2000;164:5184-91.
  • Viney JL, Mowat AM, O'Malley JM, Williamson E, Fanger NA. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998;160:5815-25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.